Development of an ELISA Assay for the Determination of SARS-CoV-2 Protein Subunit Vaccine Antigen Content

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) protein subunit vaccine is one of the mainstream technology platforms for the development of COVID-19 vaccines, and most R&D units use the receptor-binding domain (RBD) or spike (S) protein as the main target antigen. The complexit...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Lu, An, Chaoqiang, Liu, Dong, Wang, Zejun, Bian, Lianlian, He, Qian, Liu, Jianyang, Wang, Qian, Liu, Mingchen, Mao, Qunying, Hang, Taijun, Wang, Aiping, Gao, Fan, Tan, Dejiang, Liang, Zhenglun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860593/
https://www.ncbi.nlm.nih.gov/pubmed/36680102
http://dx.doi.org/10.3390/v15010062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860593/
https://www.ncbi.nlm.nih.gov/pubmed/36680102
http://dx.doi.org/10.3390/v15010062

Ejemplares similares